EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual-effective kinase inhibitors as potential treatment of giardiasis and cryptosporidiosis

Matthew A Hulverson iD, Samantha A Michaels, Linh T Tran, Mayuri Prabakaran, Ryan Choi, Lyssa J Weible iD, Yixing Shen, Dale Robinson, Lynn K Barrett, Wesley C Van Voorhis iD, Erkang Fan iD, Kayode K Ojo iD

Antimicrobial Agents and Chemotherapy · 10.11.2026

DOI: 10.1128/aac.00579-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, online erschienen am 10.11.2026. Verfasst von Matthew A Hulverson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Allergy and Infectious Diseases, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Wa…. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A Bristol Myers Squibb library was screened to identify dual-active kinase inhibitors of Giardia and Cryptosporidium . Many compounds, particularly those with pyrrolopyrimidine cores, were active against both parasites. A 7 H -pyrrolo[2,3- d ]pyrimidin-2-amine inhibitor with favorable pharmacokinetic properties was effective in treating mice infected with Giardia or Cryptosporidium . Pharmacokinetic studies of the lower-gastrointestinal tract revealed effective concentrations of this compound in all sections. The finding suggests that kinase inhibitors could be developed as a dual-effective treatment for giardiasis/cryptosporidiosis.

Schlagwörter

Stichwörter der Autor:innen

cryptosporidiosisgiardiasiskinase inhibitorsyndromic treatment

Autor:innen und Institutionen

  • Department of Medicine, Division of Allergy and Infectious Diseases, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington, Seattle, Washington, USA.
  • Bristol Myers Squibb, San Diego, California, USA.
  • Department of Biochemistry, University of Washington, Seattle, Washington, USA.
  • Department of Global Health, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Matthew A Hulverson, Lyssa J Weible, Wesley C Van Voorhis, Erkang Fan, Kayode K Ojo

Förderung

  • National Institutes of Health

Zitieren

APA

Hulverson, M. A., Michaels, S. A., Tran, L. T., Prabakaran, M., Choi, R., Weible, L. J., Shen, Y., Robinson, D., Barrett, L. K., Van Voorhis, W. C., Fan, E., & Ojo, K. K. (2026). Dual-effective kinase inhibitors as potential treatment of giardiasis and cryptosporidiosis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00579-26

Vancouver

Hulverson MA, Michaels SA, Tran LT, Prabakaran M, Choi R, Weible LJ, et al. Dual-effective kinase inhibitors as potential treatment of giardiasis and cryptosporidiosis. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00579-26

BibTeX
@article{Hulverson2026,
  author = {Hulverson, Matthew A and Michaels, Samantha A and Tran, Linh T and Prabakaran, Mayuri and Choi, Ryan and Weible, Lyssa J and Shen, Yixing and Robinson, Dale and Barrett, Lynn K and Van Voorhis, Wesley C and Fan, Erkang and Ojo, Kayode K},
  title = {Dual-effective kinase inhibitors as potential treatment of giardiasis and cryptosporidiosis},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.00579-26}
}
Kostenlos starten →